Clinical Trials · NCT00427245
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Anglo Celtic Cooperative Oncology Group
- Enrollment
- 400
- Start date
- Aug 2004
- Locations
- 66 sites, United Kingdom
- Primary endpoint
- Rate of premature menopause, defined as cessation of menses during a course of chemotherapy with no recovery for at least 12 months